All Stories

  1. CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond
  2. Characterization of Antibodies against Receptor Activity-Modifying Protein 1 (RAMP1): A Cautionary Tale
  3. Editorial: Calcitonin Gene-Related Peptide: Novel Biology and Treatments
  4. CGRP and the Calcitonin Receptor are Co-Expressed in Mouse, Rat and Human Trigeminal Ganglia Neurons
  5. The voltage-gated Ca2+ channel subunit α2δ-4 regulates locomotor behavior and sensorimotor gating in mice
  6. CGRP Administration into the Cerebellum Evokes Migraine-like Behaviors Predominately in Female Mice
  7. The voltage-gated Cav Ca2+ channel subunit α2δ-4 is required for locomotor behavior and sensorimotor gating in mice
  8. Automated detection of squint as a sensitive assay of sex-dependent calcitonin gene–related peptide and amylin-induced pain in mice
  9. Investigating Migraine-Like Behavior using Light Aversion in Mice
  10. CGRP induces migraine-like symptoms in mice during both the active and inactive phases
  11. Hypervigilance, Allostatic Load, and Migraine Prevention: Antibodies to CGRP or Receptor
  12. Female mice exhibit a more sensitive automated squint response to pain induced by CGRP and amylin
  13. PACAP Induces Light Aversion in Mice by an Inheritable Mechanism Independent of CGRP
  14. Amylin Analog Pramlintide Induces Migraine‐like Attacks in Patients
  15. Different forms of traumatic brain injuries cause different tactile hypersensitivity profiles
  16. A CGRP receptor antagonist peptide formulated for nasal administration to treat migraine
  17. PACAP induces light aversion in mice by an inheritable mechanism independent of CGRP
  18. Vascular actions of peripheral CGRP in migraine-like photophobia in mice
  19. Stimulation of Posterior Thalamic Nuclei Induces Photophobic Behavior in Mice
  20. Patients With Vestibular Migraine are More Likely to Have Occipital Headaches than those With Migraine Without Vestibular Symptoms
  21. Cross-talk signaling in the trigeminal ganglion: role of neuropeptides and other mediators
  22. Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting
  23. Behavioral and cognitive animal models in headache research
  24. CGRP-Based Migraine Therapeutics: How Might They Work, Why So Safe, and What Next?
  25. Vascular Contributions to Migraine: Time to Revisit?
  26. Current understanding of trigeminal ganglion structure and function in headache
  27. Peripherally administered calcitonin gene–related peptide induces spontaneous pain in mice: implications for migraine
  28. Cortical spreading depression as a site of origin for migraine: Role of CGRP
  29. Increased receptor activity-modifying protein 1 in the nervous system is sufficient to protect against autonomic dysregulation and hypertension
  30. CGRP in Animal Models of Migraine
  31. CGRP in the 21st century: A well-aged and blended peptide
  32. Anti-CGRP antibodies block CGRP-induced diarrhea in mice
  33. Lessons Learned from CGRP Mutant Mice
  34. Overview of Neuropeptides: Awakening the Senses?
  35. CGRP receptor activity in mice with global expression of human receptor activity modifying protein 1
  36. CGRP receptor antagonist activity of olcegepant depends on the signalling pathway measured
  37. Induction of Migraine-Like Photophobic Behavior in Mice by Both Peripheral and Central CGRP Mechanisms
  38. Induction of calcitonin gene-related peptide expression in rats by cortical spreading depression
  39. CGRP as a neuropeptide in migraine: lessons from mice
  40. CGRP induction in cystic fibrosis airways alters the submucosal gland progenitor cell niche in mice
  41. CGRP receptors and migraine
  42. Calcitonin Gene-Related Peptide (CGRP): A New Target for Migraine
  43. Photophobia and Abnormally Sustained Pupil Responses in a Mouse Model of Bradyopsia
  44. Heat Hyperalgesia and Mechanical Hypersensitivity Induced by Calcitonin Gene-Related Peptide in a Mouse Model of Neurofibromatosis
  45. Migraine meets membrane trafficking
  46. Reactive Oxygen Species Induce Procalcitonin Expression in Trigeminal Ganglia Glia
  47. CGRP and migraine: Could PACAP play a role too?
  48. Unanswered Questions in Headache: So What Is Photophobia, Anyway?
  49. Amylin Acts in the Central Nervous System to Increase Sympathetic Nerve Activity
  50. Protein Inhibitors of Activated STAT (Pias1 and Piasy) Differentially Regulate Pituitary Homeobox 2 (PITX2) Transcriptional Activity
  51. Modulation of CGRP-Induced Light Aversion in Wild-Type Mice by a 5-HT1B/DAgonist
  52. Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation
  53. CGRP induction in cystic fibrosis airways alters the submucosal gland progenitor cell niche in mice
  54. Serotonin, NO, and CGRP and Headache
  55. Neuronal Receptor Activity–Modifying Protein 1 Promotes Energy Expenditure in Mice
  56. Response to Letter by Tsuda
  57. Epigenetic regulation of the calcitonin gene–related peptide gene in trigeminal glia
  58. Receptor Activity-Modifying Protein-1 Augments Cerebrovascular Responses to Calcitonin Gene-Related Peptide and Inhibits Angiotensin II-Induced Vascular Dysfunction
  59. Receptor Activity-Modifying Protein 1 Increases Baroreflex Sensitivity and Attenuates Angiotensin-Induced Hypertension
  60. Induction of multiple photophobic behaviors in a transgenic mouse sensitized to CGRP
  61. Light aversion in mice depends on nonimage-forming irradiance detection.
  62. Genetic Regulation of CGRP and Its Actions
  63. Genetic Enhancement of Calcitonin Gene-Related Peptide-Induced Central Sensitization to Mechanical Stimuli in Mice
  64. Role of Calcitonin Gene-Related Peptide in Light-Aversive Behavior: Implications for Migraine
  65. Calcitonin gene-related peptide: an update on the biology
  66. Control of the Calcitonin Gene-related Peptide Enhancer by Upstream Stimulatory Factor in Trigeminal Ganglion Neurons
  67. Ramping it Up: RAMP1 and the Implications for Migraine
  68. Sensitization of Calcitonin Gene-Related Peptide Receptors by Receptor Activity-Modifying Protein-1 in the Trigeminal Ganglion
  69. Advent of a New Generation of Antimigraine Medications
  70. CGRP receptor antagonists: A new frontier of anti-migraine medications
  71. Calcitonin Gene-Related Peptide Receptor Activation by Receptor Activity-Modifying Protein-1 Gene Transfer to Vascular Smooth Muscle Cells
  72. Nitric oxide regulation of calcitonin gene‐related peptide gene expression in rat trigeminal ganglia neurons
  73. An unusual class of PITX2 mutations in Axenfeld‐Rieger syndrome
  74. Tumor necrosis factor‐α stimulation of calcitonin gene‐related peptide expression and secretion from rat trigeminal ganglion neurons
  75. Vitamin D Control of the Calcitonin Gene in Thyroid C Cells
  76. Cell-specific Activation of the Atrial Natriuretic Factor Promoter by PITX2 and MEF2A
  77. Regulation of the Cell-specific Calcitonin/Calcitonin Gene-related Peptide Enhancer by USF and the Foxa2 Forkhead Protein
  78. Analysis of two translocation breakpoints and identification of a negative regulatory element in patients with Rieger's syndrome
  79. Neuronal expression and regulation of CGRP promoter activity following viral gene transfer into cultured trigeminal ganglia neurons
  80. Dominant Negative Dimerization of a Mutant Homeodomain Protein in Axenfeld-Rieger Syndrome
  81. Calcium Receptor-Induced Serotonin Secretion by Parafollicular Cells: Role of Phosphatidylinositol 3-Kinase-Dependent Signal Transduction Pathways
  82. Homeobox Protein, Hmx3, in Postnatally Developing Rat Submandibular Glands
  83. Stimulation of the Calcitonin Gene-Related Peptide Enhancer by Mitogen-Activated Protein Kinases and Repression by an Antimigraine Drug in Trigeminal Ganglia Neurons
  84. NCS-1 Inhibits Insulin-stimulated GLUT4 Translocation in 3T3L1 Adipocytes through a Phosphatidylinositol 4-Kinase-dependent Pathway
  85. New insights into the molecular actions of serotonergic antimigraine drugs
  86. Antagonistic Regulation of <I>Dlx2</I> Expression by PITX2 and Msx2: Implications for Tooth Development
  87. Autoregulation of Cell-specific MAP Kinase Control of the Tryptophan Hydroxylase Promoter
  88. Identification of a Dominant Negative Homeodomain Mutation in Rieger Syndrome
  89. Developmental regulation of tryptophan hydroxylase messenger RNA expression and enzyme activity in the raphe and its target fields
  90. Differential Regulation of Mitogen-Activated Protein Kinase-Responsive Genes by the Duration of a Calcium Signal
  91. Gene transfer of calcitonin gene-related peptide to cerebral arteries
  92. Multifunctional Role of the Pitx2 Homeodomain Protein C-Terminal Tail
  93. Regulation of Calcitonin Gene-Related Peptide Secretion by a Serotonergic Antimigraine Drug
  94. Transcriptional Antagonism between Hmx1 and Nkx2.5 for a Shared DNA-binding Site
  95. The Molecular Basis of Rieger Syndrome
  96. Serotonergic Repression of Mitogen-Activated Protein Kinase Control of the Calcitonin Gene-Related Peptide Enhancer
  97. Measurement of tryptophan hydroxylase mRNA levels by competitive RT-PCR
  98. BDNF induction of tryptophan hydroxylase mRNA levels in the rat brain
  99. Requirement of the MASH-1 transcription factor for neuroendocrine differentiation of thyroid C cells
  100. Repression of the Calcitonin Gene-Related Peptide Promoter by 5-HT1Receptor Activation
  101. Tissue-specific glucocorticoid regulation of tryptophan hydroxylase mRNA levels
  102. Binding of Upstream Stimulatory Factor and a Cell-specific Activator to the Calcitonin/Calcitonin Gene-related Peptide Enhancer
  103. Thyroid parafollicular cells
  104. Expression and development of a functional plasmalemmal 5-hydroxytryptamine transporter by thyroid follicular cells.
  105. Induction of a serotonergic and neuronal phenotype in thyroid C-cells
  106. Serotonergic Neuronal Properties in C-Cell Lines
  107. Retinoic acid repression of cell-specific helix-loop-helix-octamer activation of the calcitonin/calcitonin gene-related peptide enhancer.
  108. Retinoic acid is enriched in Hensen's node and is developmentally regulated in the early chicken embryo.
  109. A rapid PCR protocol for identification of differentially expressed genes from a cDNA library.
  110. Neuronal properties of a thyroid C-cell line: partial repression by dexamethasone and retinoic acid.
  111. Characterization of the calcitonin/CGRP gene in Williams syndrome
  112. Isolation of cDNA clones encoding small nuclear ribonucleoparticle-associated proteins with different tissue specificities.
  113. Neuronal Expression of chimeric genes in transgenic mice
  114. Molecular cloning of a brain-specific calcium/calmodulin-dependent protein kinase.
  115. Neuron-specific alternative RNA processing in transgenic mice expressing a metallothionein-calcitonin fusion gene
  116. Neuron-specific alternative RNA processing in neuroendocrine gene expression
  117. Identification of the tip-encoded receptor in bacterial sensing
  118. Role of Silicon in Diatom Metabolism
  119. Separation of Signal Transduction and Adaptation Functions of the Aspartate Receptor in Bacterial Sensing
  120. Information Processing in a Sensory System